---
schema_version: "secwatch.filing_event.v1"
accession: "0001213900-25-121374"
form_type: "8-K"
ticker: "NDRA"
cik: "0001681682"
company_name: "ENDRA Life Sciences Inc."
filed_at: "2025-12-15T23:59:59+00:00"
generated_at: "2026-05-16T13:13:58.640780+00:00"
event_type: "other_material"
sentiment: "negative"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# ENDRA Life Sciences authorized shares increased from 20M to 1B; officer exculpation rejected

## Summary
- Authorized common shares increased from 20M to 1B via Certificate of Amendment effective Dec 10, 2025.
- Stockholders rejected officer exculpation amendment (358,746 for, 63,603 against, 3,587 abstain).
- Second Amendment to 2016 Omnibus Incentive Plan approved (406,837 for, 15,223 against).
- Four director nominees elected with >418K votes each; RBSM LLP ratified as auditor (680,031 for).

## SEC filing metadata
- accession: 0001213900-25-121374
- form_type: 8-K
- ticker: NDRA
- cik: 0001681682
- company_name: ENDRA Life Sciences Inc.
- filed_at: 2025-12-15T23:59:59+00:00
- event_type: other_material
- sentiment: negative
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 5.02, 5.03, 5.07, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1681682/000121390025121374/0001213900-25-121374-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1681682/000121390025121374/ea0269386-8k_endra.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001213900-25-121374
- JSON: https://secwatch.observer/filing/0001213900-25-121374.json
- Plain text: https://secwatch.observer/filing/0001213900-25-121374.txt

## Key facts
- Governance Changes
  ENDRA Life Sciences Inc.: Increased authorized common stock from 20,000,000 shares to 1,000,000,000 shares via Certificate of Amendment to Fourth Amended and Restated Certificate of Incorporation (effective 2025-12-10).
  - Change: charter amendment
  - Effective: 2025-12-10
  source text: At the Annual Meeting, the Company’s stockholders approved and adopted a Certificate of Amendment to the Company’s Fourth Amended and Restated Certificate of Incorporation (the “Certificate of Incorporation”) to increase the number of authorized shares of Company’s common stock, par value $0.0001 (the “Common Stock”), from 20,000,000 shares to 1,000,000,000 shares (the “Share Increase Amendment”). The Share Increase Amendment was filed with the Secretary of State of the State of Delaware on December 10, 2025 and was effective upon filing.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1681682/000121390025121374/0001213900-25-121374-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.